Polyoma Viruses

The Mouse in Biomedical Research

Volumn 2, Issue , 2007, Pages 105-139

  Benjamin, Thomas L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37849051119     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369454-6/50033-9     Document Type: Chapter

References (384)

1. Agostinis P., Donella-Deana A., Van Hoof C., et al. A comparative study of the phosphotyrosyl phosphatase specificity of protein phosphatase type 2A and phosphotyrosyl phosphatase type 1B using phosphopeptides and the phosphoproteins p50/HS1 c-Fgr and Lyn. Eur J Biochem 1996, 236:548-557.
2. Allison A.C., Law L.W. Effects of antilymphocyte serum on virus oncogenesis. Proc Soc Exp Biol. Med 1968, 127:207-212.
3. Amalfitano A., Martin L.G., Fluck M.M. Different roles for two enhancer domains in the organ and age-specific pattern of polyomavirus replication in the mouse. Mol. Cell. Biol. 1992, 12:3628-3635.
4. Anderson H.A., Chen Y., Norkin L.C. Bound simian virus 40 translocates to caveolin-enriched membrane domains and its entry is inhib-ited by drugs that selectively disrupt caveolae. Mol Biol. Cell 1996, 7:1825-1834.
5. Aposhian H.V., Qasba P.K., Osterman J.V., Waddell A. Polyoma pseudovirions: an experimental model for the development of DNA for gene therapy. Fed Proc 1972, 31:1310-1314.
6. Argilla D., Chin K., Singh M., et al. Absence of telomerase and short-ened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes. Cancer Cell 2004, 6:373-385.
7. Balmain A. Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell 2002, 108:145-152.
8. Balmain A., Harris C. Carcinogenesis in mouse and human cells: parallels and paradoxes. Carcinogenesis 2000, 21:371-377.
9. Baron-Van Evercooren A., Jensen N.A., Wyss M.T., et al. Transgenic mice expressing polyoma virus large T antigen in astrocytes develop severe dysmyelination of the central nervous system. Lab Invest 1992, 66:39-53.
10. Barouch D.H., Harrison S.C. Interactions among the major and minor coat proteins of polyomavirus. J. Virol. 1994, 68:3982-3989.
11. Bauer P.H., Bronson R.T., Fung S.C., et al. Genetic and structural analy-sis of a virulence determinant in polyomavirus VP1. J Virol 1995, 69:7925-7931.
12. Bauer P.H., Cui C., Liu R., et al. Discrimination between sialic acid-containing receptors and pseudoreceptors regulates polyomavirus spread in the mouse. J. Virol. 1999, 73:5826-5832.
13. Bautch V.L., Toda S., Hassell J.A., Hanahan D. Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T onco-gene. Cell 1987, 51:529-537.
14. Bautch V.L., Toda S., Hassell J.A., Hanahan D. Tissue specificity of oncogene action: endothelial cell tumours in polyoma middle T transgenic mice. IARC Sci Publ 1989, 96:255-266.
15. Behringer R.R., Peschon J.J., Messing A., et al. Heart and bone tumors in transgenic mice. Proc Natl Acad Sci USA 1988, 85:2648-2652.
16. Bendig M.M., Thomas T., Folk W.R. Viable deletion mutant in the medium and large T-antigen-coding sequences of the polyoma virus genome. J Virol 1980, 33:1215-1220.
17. Benjamin T.L. Relative target sizes for the inactivation of the trans-forming and reproductive abilities of polyoma virus. Proc Natl Acad Sci USA 1965, 54:121-124.
18. Benjamin T.L. Host range mutants of polyoma virus. Proc Natl Acad Sci USA 1970, 67:394-399.
19. Benjamin T.L. Methods of cell transformation by tumor viruses. Methods Cell Biol 1974, VIII:367-437. D. Prescott (Ed.).
20. Benjamin T.L. Polyoma virus: old findings and new challenges. Virology 2001, 289:167-173.
21. Berke Z., Dalianis T. Studies on polyomavirus persistence and polyomavirus-induced tumor development in relation to the immune system. Adv Cancer Res 2000, 79:249-276.
22. Berke Z.S., Palmer T., Bergman, et al. A short peptide eluted from the H-2Kb molecule of a polyomavirus-positive tumor corresponds to poly-omavirus large T antigen peptide at amino acids 578 to 585 and induces polyomavirus-specific immunity. J. Virol. 1996, 70:3093-3097.
23. Berke Z., Wen T., Klein G., Dalianis T. Polyoma tumor develop-ment in neonatally polyoma-virus-infected CD4-/-and CD8-/-single knockout and CD4-/-8-/-double knockout mice. Int J Cancer 1996, 67:405-408.
24. Bikel I., Montano X., Agha M.E., et al. SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen. Cell 1987, 48:321-330.
25. Blattner W.A. Human retroviruses: their role in cancer. Proc Assoc Am Physicians 1999, 111:563-572.
26. Bolen J.B., Fisher S.E., Chowdhury K., et al. A determinant of poly-omavirus virulence enhances virus growth in cells of renal origin. J Virol. 1985, 53:335-339.
27. Bond S.B., Howley P.M., Takemoto K.K. Characterization of K virus and its comparison with polyoma virus. J. Virol. 1978, 28:337-343.
28. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., Greenberg M.E. Cell survival promoted by the Ras-MAPK signaling pathway by tran-scription p-dependent and-independent mechanisms. Science 1999, 286:1358-1362.
29. Breau W.C., Atwood W.J., Norkin L.C. Class I major histocom-patibility proteins are an essential component of the simian virus 40 receptor. J Virol 1992, 66:2037-2045.
30. Bronson R., Dawe C., Carroll J., Benjamin T. Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc. Proc Natl Acad Sci USA 1997, 94:7954-7958.
31. Burger M.M. A difference in the architecture of the surface membrane of normal and virally transformed cells. Proc Natl Acad Sci USA 1969, 62:994-1001.
32. + T cells. J Immunol. 2003, 171:17-21.
33. Cahan L.D., Paulson J.C. Polyoma virus adsorbs to specific sialyloligosaccharide receptors on erythrocytes. Virology 1980, 103:505-509.
34. Cahan L.D., Singh R., Paulson J.C. Sialyloligosaccharide recep-tors of binding variants of polyomavirus. Virology 1983, 130:281-289.
35. Campbell K.S., Ogris E., Burke B., et al. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc Natl Acad Sci USA 1994, 91:6344-6348.
36. Cardone M.H., Roy N., Stennicke H.R., et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998, 282:1318-1321.
37. Carmichael G.G., Benjamin T.L. Identification of DNA sequence changes leading to loss of transforming ability in polyoma virus. J Biol. Chem 1980, 255:230-235.
38. Carmichael G.G., Schaffhausen B.S., Dorsky D.I., Oliver D.B., Benjamin T.L. Carboxy terminus of polyoma middle-sized tumor antigen is required for attachment to membranes associated protein kinase activities and cell transformation. Proc Natl Acad Sci USA 1982, 79:3579-3583.
39. Carmichael G., Schaffhausen B.S., Mandel G., Liang T.J., Benjamin T.L. Transformation by polyoma virus is drastically reduced by sub-stitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen. Proc Natl Acad Sci USA 1984, 81:679-683.
40. Carroll J.P., Fung J.S., Bronson R.T., Razvi E., Benjamin T.L. Radiation-resistant and radiation-sensitive forms of host resistance to poly-omavirus. J. Virol 1999, 73:1213-1218.
41. Carter J., Madeleine M.M., Wipf G.C., et al. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst. 2003, 95:1522-1530.
42. Caruso M., Belloni L., Sthandier O., Amati P., Garcia M.I. alpha;4 beta;1 integin acts as a cell receptor for murine polyomavirus at the postattachment level. J Virol. 2003, 77:3913-3921.
43. Caruso M., Cavaldesi M., Gentile M., Sthandier O., Amati P., Garcia M.I. Role of sialic acid-containing molecules and the alpha4betal integrin receptor in the early steps of polyomavirus infection. J Gen Virol 2003, 84:2927-2936.
44. Caspar D.L.D., Klug A. Basic Mechanisms in Animal Virus Biology. Symposia on Quantitative Biology 1962, vol. 27:1-24. Long Island Biological Association, Cold Spring Harbor NY, pp. 1-24.
45. Chang S.S., Hildemann W.H. Inheritance of susceptibility to poly-oma virus in mice. J Natl Cancer Inst 1964, 33:303-313.
46. Chen L., Wang X., Fluck M. Independent contributions of poly-omavirus middle T and small T to the regulation of early anmd late gene expression and DNA replication. J. Virol. 2006, 80:7295-7307.
47. Chen M.H., Benjamin T. Roles of N-glycans with alpha26 as well as alpha23 linked sialic acid in infection by polyoma virus. Virology 1997, 233:440-442.
48. Chen M.C., Redenius D., Osati-Ashtiani F., Fluck M.M. Enhancer-mediated role for polyomavirus middle T/small T in DNA replica-tion. J Virol 1995, 69:326-333.
49. Chen X.S., Stehle T., Harrison S.C. Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entry. Embo J 1998, 17:3233-3240.
50. Cho HJ., Seiberg M., Georgoff L, Teresky A.K., Marks J.R., Levine A.J. Impact of the genetic background of transgenic mice upon the formation and timing of choroid plexus papillomas. J Neurosci Res 1989, 24:115-122.
51. Cho S., Tian Y., Benjamin T.L. Binding of p300/CBP co-activa-tors by polyoma large T antigen. J. Biol. Chem 2001, 276:33533-33539.
52. Choi Y.W., Lee I.C., Ross S.R. Requirement for the simian virus 40 small tumor antigen in tumorigenesis in transgenic mice. Mol Cell Biol 1988, 8:3382-3390.
53. Christofori G., Naik P., Hanahan D. Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during beta-cell tumorigenesis. Nat Genet 1995, 10:196-201.
54. Chromy L.R., Pipas J.M., Garcea R.L. Chaperone-mediated in vitro assembly of Polyomavirus capsids. Proc Natl Acad Sci USA 2003, 100:10477-10482.
55. Cole C.N., Conzen S.D. Polyomaviridae: the viruses and their replication. Fields Virology 2001, 2141. Lippincott Williams amp; Wilkins, Philadelphia. D. Knipe, M. Peter (Eds.).
56. Cook D.N., Hassell J.A. The amino terminus of polyomavirus middle T antigen is required for transformation. J Virol. 1990, 64:1879-1887.
57. Courtneidge S.A., Smith A.E. Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature 1983, 303:435-439.
58. Couture L.A., Lehman J.M. Polyomavirus enhancer requirements for expression in embryonal carcinoma cells. Int J Dev Biol. 1993, 37:125-133.
59. Crick F.H., Watson J.D. Structure of small viruses. Nature 1956, 177:473-475.
60. Crick F.H., Watson J.D. Virus structure: general principles. Nature of Viruses 1957, CIBA. W.A. Miller (Ed.).
61. Cripe T.P., Delos S.E., Estes P.A., Garcea R.L. In vivo and in vitro association of hsc70 with polyomavirus capsid proteins. J Virol. 1995, 69:7807-7813.
62. Cullere X., Rose P., Thathamangalam U., et al. Serine 257 phospho-rylation regulates association of polyomavirus middle T antigen with 14-3-3 proteins. J Virol 1998, 72:558-563.
63. Dabrosin C., Palmer K., Muller W.J., Gauldie J. Estradiol pro-motes growth and angiogenesis in polyoma middle T transgenic mouse mammary tumor expiants. Breast Cancer Res Treat 2003, 78:1-6.
64. Dahl J., Jurczak A., Cheng L.A., Baker D.C., Benjamin T.L. Evidence of a role for phosphatidylinositol 3-kinase activation in the block-ing of apoptosis by polyomavirus middle T antigen. J. Virol. 1998, 72:3221-3226.
65. Dahl J., Thathamangalam U., Freund R., Benjamin T.L. Functional asymmetry of the regions juxtaposed to the membrane-binding sequence of polyomavirus middle T antigen. Mol Cell Biol 1992, 12:5050-5058.
66. Dahl J., You J., Benjamin T.L. Induction and utilization of an ATM signaling pathway by polyomavirus. J. Virol. 2005, 79:13007-13017.
67. Datta S.R., Brunet A., Greenberg M. Cellular survival: a play in three Akts. Genes Dev. 1999, 13:2905-2927.
68. Dawe C. Salivary gland neoplasms in the role of normal mesenchyme during salivary gland morphogenesis. Epithelial-Mesenchymal Interactions Fleischmajer 1968, 295-312. Williams amp; Wilkins Co.
69. Dawe C.J. Nakahara memorial lecture: polyoma tumors in mice and x cell tumors in fish viewed through telescope and microscope. Japan Sci. Soc. 1981, 19-49. Press Phyletic approaches to Cancer.
70. Dawe C.J., Freund R., Abromson-Leeman S.R., Dubensky, et al. T-cell lymphomas emerging as epineoplasms in mice bearing transplanted poly-oma virus-induced salivary gland tumors. Cancer Res 1990, 50:5643S-5648S.
71. Dawe C.J., Freund R., Barncastle J.P., Dubensky T.W., Mandel G., Benjamin T.L. Necrotizing arterial lesions in mice-bearing tumors induced by polyoma virus. J. Exp Pathol. 1987, 3:177-201.
72. Dawe C.J., Freund R., Mandel G., Ballmer-Hofer K., Talmage D.A., Benjamin T.L. Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. Am J Pathol. 1987, 127:243-261.
73. Dawe C.J., Morgan W.D., Slatick M.S. Influence of epithelio-mesenchymal interactions on tumor induction by polyoma virus. Int. J. Cancer 1966, 1:419-450.
74. Dawe C.J., Whang-Peng J., Morgan W.D., Hearon E.C., Knutsen T. Epithelial origin of polyoma salivary tumors in mice: evidence based on chromosome-marked cells. Science 1971, 171:394-397.
75. Deininger P., Esty A., LaPorte P., Friedmann T. Nucleotide sequence and genetic organization of the polyoma late region: features common to the polyoma early region and SV40. Cell 1979, 18:771-779.
76. Deininger P.L., Esty A., LaPorte P., Hsu H., Friedmann T. The nucleotide sequence and restriction enzyme sites of the polyoma genome. Nucleic Acids Res 1980, 8:855-860.
77. de Villiers J., Schaffner W., Tyndall C., Lupton S., Kamen R. Polyoma virus DNA replication requires an enhancer. Nature 1984, 312:242-246.
78. Dey D.C., Bronson R.P., Dahl J., Carroll J.P., Benjamin T.L. Accelerated development of polyoma tumors and embryonic lethality: dif-ferent effects of p53loss on related mouse backgrounds. Cell Growth Differ 2000, 11:231-237.
79. Dey D., Dahl J., Cho S., Benjamin T.L. Induction and bypass of p53during productive infection by polyomavirus. J Virol. 2002, 76:9526-9532.
80. Dilworth S.M. Polyoma virus middle T antigen and its role in identi-fying cancer-related molecules. Nat Rev Cancer 2002, 2:951-956.
81. Dilworth S.M., Brewster C.E., Jones M.D., Lanfrancone L., Pelicci G., Pelicci P.G. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc. Nature 1994, 367:87-90.
82. Drake D.R., 3rd Lukacher A.E. Beta 2-microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis. Virology 1998, 252:275-284.
83. Druker B.J., Sibert L., Roberts T.M. Polyomavirus middle T-antigen NPTY mutants. J. Virol 1992, 66:5770-5776.
84. Dubensky T.W., Freund R., Dawe C.J., Benjamin T.L. Polyomavirus replication in mice: influences of VP1 type and route of inoculation. J Virol. 1991, 65:342-349.
85. Dubensky T.W, Murphy F.A., Villarreal L.P. Detection of DNA and RNA virus genomes in organ systems of whole mice: patterns of mouse organ infection by polyomavirus. J Virol 1984, 50:779-783.
86. Dulbecco R., Hartwell L.H., Vogt M. Induction of cellular DNA synthesis by polyoma virus. Proc Natl Acad Sci USA 1965, 53:403-410.
87. Dwenger A., Rosenthal F., Machein M., Waller C., Spyridonidis A. Transplanted bone marrow cells preferentially home to the vessels of in situ generated murine tumors rather than of normal organs. Stem Cells 2004, 22:86-92.
88. Eckhart W Viruses and human cancer. . Sci. Prog 1998, 81:315-328. (Pt 4).
89. Eddy B.E. Polyomavirus. The Mouse in Biomedical Research 1982, vol. II:293-311. Academic Press.
90. Efrat S., Baekkeskov S., Lane D., Hanahan D. Coordinate expres-sion of the endogenous p53gene in beta cells of transgenic mice expressing hybrid insulin-SV40 T antigen genes. Embo J 1987, 6:2699-2704.
91. Eisenberg D. A problem for the theory of biological structure. Nature 1982, 295:99-100.
92. Eisenmann K.M., VanBrocklin M.W., Staffend N.A., Kitchen S.M., Koo H.M. Mitogen-activated protein kinase pathway-dependent tumor-specific survival signaling in melanoma cells through inactivation of the proapoptotic protein bad. Cancer Res 2003, 63:8330-8337.
93. Emtage P.C., Wan Y., Hitt M., et al. Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models. Hum Gene Ther 1999, 10:697-709.
94. Ewald D., Li M., Efrat S., et al. Time-sensitive reversal of hyperpla-sia in transgenic mice expressing SV40 T antigen. Science 1996, 273:1384-1386.
95. Farmerie W.G., Folk W.R. Regulation of polyomavirus transcrip-tion by large tumor antigen. Proc Natl Acad Sci USA 1984, 81:6919-6923.
96. Feigenbaum L., Hinrichs S.H., Jay G. JC virus and simian virus 40 enhancers and transforming proteins: role in determining tissue speci-ficity and pathogenicity in transgenic mice. J Virol. 1992, 66:1176-1182.
97. Fellner T., Lackner D.H., Hombauer H., et al. A novel and essential mechanism determining specificity and activity of protein phosphatase 2A (PP2A) in vivo. Genes Dev 2003, 17:2138-2150.
98. Feunteun J., Sompayrac L., Fluck M., Benjamin T. Localization of gene functions in polyoma virus DNA. Proc Natl Acad Sci USA 1976, 73:4169-4173.
99. Fisher G.H., Orsulic S., Holland E., et al. Development of a flexible and specific gene delivery system for production of murine tumor models. Oncogene 1999, 18:5253-5260.
100. Fluck M.M., Benjamin T.L. Comparisons of two early gene func-tions essential for transformation in polyoma virus and SV-40. Virology 1979, 96:205-228.
101. Fluck M.M., Staneloni R.J., Benjamin T.L. Hr-t and ts-a: two early gene functions of polyoma virus. Virology 1977, 77:610-624.
102. Folkman J., Hanahan D. Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symp 1991, 22:339-347.
103. Forstova J., Krauzewicz N., Sandig V., et al. Polyoma virus pseudo-capsids as efficient carriers of heterologous DNA into mammalian cells. Hum Gene Ther 1995, 6:297-306.
104. Forstova J., Krauzewicz N., Wallace S., et al. Cooperation of struc-tural proteins during late events in the life cycle of polyomavirus. J Virol. 1993, 67:1405-1413.
105. Frearson P.M., Crawford L.V. Polyoma virus basic proteins. J. Gen Virol 1972, 14:141-155.
106. Freund R., Bauer P.H., Crissman H.A., Bradbury E.M., Benjamin T.L. Host range and cell cycle activation properties of polyomavirus large T-antigen mutants defective in pRB binding. J Virol 1994, 68:7227-7234.
107. Freund R., Bronson R.T., Benjamin T.L. Separation of immortal-ization from tumor induction with polyoma large T mutants that fail to bind the retinoblastoma gene product. Oncogene 1992, 7:1979-1987.
108. Freund R., Calderone A., Dawe C.J., Benjamin T.L. Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T anti-gen. J Virol 1991, 65:335-341.
109. Freund R., Dawe C.J., Benjamin T.L. Duplication of noncoding sequences in polyomavirus specifically augments the development of thymic tumors in mice. J Virol 1988, 62:3896-3899.
110. Freund R., Dawe C.J., Carroll J.P., Benjamin T.L. Changes in frequency morphology and behavior of tumors induced in mice by a poly-oma virus mutant with a specifically altered oncogene. Am J Pathol 1992, 141:1409-1425.
111. Freund R., Dubensky T., Bronson R., Sotnikov A., Carroll J., Benjamin T. Polyoma tumorigenesis in mice: evidence for dominant resistance and dominant susceptibility genes of the host. Virology 1992, 191:724-731.
112. Freund R., Garcea R.L., Sahli R., Benjamin T.L. A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior. J. Virol. 1991, 65:350-355.
113. Freund R., Mandel G., Carmichael G.G., Barncastle J.P., Dawe C.J., Benjamin T.L. Polyomavirus tumor induction in mice: influences of viral coding and noncoding sequences on tumor profiles. J Virol 1987, 61:2232-2239.
114. Freund R., Sotnikov A., Bronson R.T., Benjamin T.L. Polyoma virus middle T is essential for virus replication and persistence as well as for tumor induction in mice. Virology 1992, 191:716-723.
115. Fried M. Cell-transforming ability of a temperature-sensitive mutant of polyoma virus. Proc Natl Acad Sci USA 1965, 53:486-491.
116. Fried H., Cahan L.D., Paulson J.C. Polyomavirus recognizes specific sialyoligosaccharide receptors on host cells. Virology 1981, 109:188-192.
117. Friedmann T., Esty A., LaPorte P., Deininger P. The nucleotide sequence and genome organization of the polyoma early region: extensive nucleotide and amino acid homology with SV40. Cell 1979, 17:715-724.
118. Fujimura F.K., Deininger P.L., Friedmann T., Linney E. Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells. Cell 1981, 23:809-814.
119. Gai D., Zhao R., Li D., Finkielstein C.V., Chen X.S. Mechanisms of conformational change for a replicative hexameric helicase of SV40 large tumor antigen. Cell 2004, 119:47-60.
120. Galiana E., Borde L, Marin P., et al. Establishment of permanent astroglial cell lines able to differentiate in vitro from transgenic mice carrying the polyoma virus large T gene: an alternative approach to brain cell immortalization. J Neurosci Res 1990, 26:269-277.
121. Garcea R.L., Ballmer-Hofer K., Benjamin T.L. Virion assembly defect of polyomavirus hr-t mutants: underphosphorylation of major capsid protein VP1 before viral DNA encapsidation. J Virol 1985, 54:311-316.
122. Garcea R.L., Benjamin T.L. Host range transforming gene of polyoma virus plays a role in virus assembly. Proc Natl Acad Sci USA 1983, 80:3613-3617.
123. Garcea R.L., Imperiale M.J. Simian virus 40 infection of humans. J Virol 2003, 77:5039-5045.
124. Garcea R.L., Liddington R.C. Structural biology of poly- omaviruses. Structural Biology of Viruses 1997, 187-208. Oxford Press. W. Chiu, R.M. Burnett, R.L. Garcea (Eds.).
125. Garcea R.L., Salunke D.M., Caspar D.L. Site-directed mutation affecting polyomavirus capsid self-assembly in vitro. Nature 1987, 329:86-87.
126. Gardner M.B., Henderson B.E., Menck H., Parker J., Estes J.D., Huebner R. Spontaneous tumors and c-type virus in polyoma-infected aging wild house mice. Journal of the National Cancer Institute 1974, 52:979-981.
127. Gaudray P., Clertant P., Cuzin F. ATP phosphohydrolase (ATPase) activity of a polyoma virus T antigen. Eur J Biochem 1980, 109:553-560.
128. Gazdar A.F., Butel J.S., Carbone M. SV40 and human tumours: myth association or causality?. Nat Rev Cancer 2002, 2:957-964.
129. Genevaux P., Lang F., Schwager F., et al. Simian virus 40 T antigens and J domains: analysis of Hsp40 cochaperone functions in Escherichia coli. J Virol 2003, 77:10706-10713.
130. Gilbert J.M., Benjamin T.L. Early steps of polyomavirus entry into cells. J Virol 2000, 74:8582-8588.
131. Gilbert J.M., Benjamin T.L. The uptake pathway of polyoma virus via ganglioside GD1a. J. Virol. 2004, 78:12259-12267.
132. Gilbert J., Dahl J., Riney C., et al. Ganglioside GD1a restores infectability to mouse cells lacking functional receptors for polyoma virus. J. Virol. 2005, 79:615-618.
133. Gilbert J.M., Goldberg I.G., Benjamin T.L. Cell penetration and trafficking of polyomavirus. J Virol 2003, 77:2615-2622.
134. Gilbert J., Ou W., Silver J., Benjamin T. Downregulation of Protein Disulfide Isomerase Inhibits Infection by the Mouse Polyoma Virus. J. Virol. 2006, 80. (in press).
135. Gillet R., Cavard C., Grimber G., Briand P., Joulin V. Hepatic expression of SV40 small-T antigen blocks the in vivo CD95-mediated apoptosis. Biochem Biophys Res Commun 2001, 284:369-376.
136. Glover H.R., Brewster C.E., Dilworth S.M. Association between src-kinases and the polyoma virus oncogene middle T-antigen requires PP2A and a specific sequence motif. Oncogene 1999, 18:4364-4370.
137. Goodman R.a.G.RJ. Atlas of the Face in Genetic Disorders 1977, 382-383. Mosby St. Louis. 2nd ed.
138. Gordon J., Del Valle L., Otte J., Khalili K. Pituitary neoplasia induced by expression of human neurotropic polyomavirus JCV early genome in transgenic mice. Oncogene 2000, 19:4840.
139. Gottlieb K., Villarreal L.P. The distribution and kinetics of poly-omavirus in lungs of intranasally infected newborn mice. Virology 2000, 266:52-65.
140. Gottlieb K., Villarreal L.P. Natural biology of polyomavirus middle T antigen. Microbiol Mol Biol Rev 2001, 65:288-318.
141. Greenberg N.M., DeMayo F., Finegold M.J., et al. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995, 92:3439-3443.
142. Greenlee J.E. Pathogenesis of K virus infection in newborn mice. Infect Immun 1979, 26:705-713.
143. Greenlee J.E. Chronic infection of nude mice by murine K papovavirus. J Gen Virol 1986, 67:1109-1114. (Pt 6).
144. Greenlee J.E., Clawson S.H., Phelps R.C, Stroop W.G. Distribution of K-papovavirus in infected newborn mice. J Comp Pathol. 1994, 111:259-268.
145. Greenlee J.E., Dodd W.K. Reactivation of persistent papovavirus K infection in immunosuppressed mice. J Virol. 1984, 51:425-429.
146. Greenlee J.E., Dodd W.K., Oster-Granite M.L. An in vitro assay for K-papovavirus of mice. J Virol. Methods 1982, 4:139-146.
147. Greenlee J.E., Law M.F. Persistent infection and transformation of mouse glial cultures by K virus a murine papovavirus. J Gen Virol. 1984, 65:1253-1258. (Pt 7).
148. Greenlee J.E., Law M.F. Interaction of K papovavirus with hamster cells: transforma-tion of glial cells in vitro but failure of the virus to produce central nervous system tumors in vivo. Arch Virol. 1985, 83:207-215.
149. Greenlee J.E., Phelps R.C., Stroop W.G. The major site of murine K papovavirus persistence and reactivation is the renal tubular epithelium. Microb Pathog 1991, 11:237-247.
150. Griffin B.E., Dilworth S.M. Polyomavirus: an overview of its unique properties. Adv Cancer Res 1983, 39:183-268.
151. Griffith J.P., Griffith D.L., Rayment I., Murakami W.T., Caspar D.L. Inside polyomavirus at 25-A resolution. Nature 1992, 355:652-654.
152. Griffin B.E., Maddock C. New classes of viable deletion mutants in the early region of polyoma virus. J Virol 1979, 31:645-656.
153. Gross L. A filterable agent recovered from Ak leukemic extracts causing salivary gland carcinomas in C3H mice. Proc Soc Exp Biol. Med 1953, 83:414-421.
154. Gross L. Mouse leukemia. Oncogenic Viruses 1983, vol. 2:305-443. Pergamon Press, Elmsford NY. 3rd ed. L. Gross (Ed.).
155. The polyoma virus. Oncogenic Viruses 1983, vol. 2:737-825. Pergamon Press, Elmsford NY. 3rd ed. L. Gross (Ed.).
156. Guy CT., Cardiff R.D., Muller W.J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992, 12:954-961.
157. Guy C.T., Muthuswamy S.K., Cardiff R.D., Soriano P., Muller W.J. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev 1994, 8:23-32.
158. Hager J.H., Hodgson J.G., Fridlyand J., Hariono S., Gray J.W., Hanahan D. Oncogene expression and genetic background influence the frequency of DNA copy number abnormalities in mouse pancreatic islet cell carcinomas. Cancer Res 2004, 64:2406-2410.
159. Hahnfeldt P., Panigrahy D., Folkman J., Hlatky L. Tumor development under angiogenic signaling: a dynamical theory of tumor growth treatment response and postvascular dormancy. Cancer Res 1999, 59:4770-4775.
160. Han Lee E.D., Kemball C.C., Wang J., Dong Y., Stapler D.C., Hamby K.M., Gangappa S., Newell K.A., Person T.C., Lukacher A.E., Larsen C.P. A mouse model for polyomavirus-associated nephropathy of kidney transplants. Am J Transplant 2006, 6:913-922. (5 Pt 1).
161. Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985, 315:115-122.
162. Harrod F.A., Kettman J.R. Diverse classes of T-cell lymphomas arise in T-lymphocyte-inductive epitheliomas of the mouse salivary gland. LeukRes 1992, 16:899-917.
163. Harvey D.M., Levine A.J. p53alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibrob-lasts. Genes Dev 1991, 5:2375-2385.
164. Haselbeck A., Schickaneder E., von der Eltz H., Hosel W. Structural characterization of glycoprotein carbohydrate chains by using diagoxigenin-labeled lectins on blots. Anal Biochem 1990, 191:25-30.
165. Hattori J., Carmichael G.G., Benjamin T.L. DNA sequence alterations in Hr-t deletion mutants of polyoma virus. Cell 1979, 16:505-513.
166. Heinrichs S., Deppert W. Apoptosis or growth arrest: modulation of the cellular response to p53by proliferative signals. Oncogene 2003, 22:555-571.
167. Herbomel P., Bourachot B, Yaniv M. Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 1984, 39:653-662.
168. Herzig M., Novatchkova M., Christofori G. An unexpected role for p53in augmenting SV40 large T antigen-mediated tumorigenesis. Biol Chem 1999, 380:203-211.
169. Hodgson G., Hager J.H., Volik S., et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet 2001, 29:459-464.
170. Holtz A.H. Results of haematological trials in the netherlands. Bibl Haematol 1964, 18:86-91.
171. Hoot G.P., Kettman J.R. Extra-thymic immature T cells: devel-opment in polyoma virus-induced murine salivary gland tumors. Eur J Immunol 1989, 19:1991-1998.
172. Hoot G.P., Kettman J.R. Primary polyoma virus-induced murine thymic epithelial tumors. A tumor model of thymus physiology. Am J Pathol 1989, 135:679-695.
173. Ichaso N., Dilworth S.M. Cell transformation by the middle T-antigen of polyoma virus. Oncogene 2001, 20:7908-7916.
174. Ikeda K., Domes K., ter Meulen V. Morphological and immuno-histochemical studies of the central nervous system involvement in papovavirus K infection in mice. Acta Neuropathol (Berl) 1988, 77:175-181.
175. Jahkola M. Inheritance of resistance to polyoma tumorigenesis in inbred mice. J Natl Cancer Inst 1965, 35:595-601.
176. Jones N.C., Rigby P.W., Ziff E.B. Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses. Genes Dev 1988, 2:267-281.
177. Kanai F., Marignani P.A., Sarbassova D., et al. TAZ: a novel tran-scriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. Embo J 2000, 19:6778-6791.
178. Kanda T., Takemoto K.K. Analysis of T antigen and viral DNA in mouse cells transformed by K virus a nononcogenic murine papovavirus. J Virol. 1984, 50:954-956.
179. Kaplan D.R., Whitman M., Schaffhausen B., et al. Phosphatidylinositol metabolism and polyoma-mediated transformation. Proc Natl Acad Sci USA 1986, 83:3624-3628.
180. Katinka M., Vasseur M., Montreau N., Yaniv M., Blangy D. Polyoma DNA sequences involved in control of viral gene expression in murine embryonal carcinoma cells. Nature 1981, 290:720-722.
181. Kemball C.C., Lee E.D., Vezys V., Pearson T.C., Larsen C.P., Lukacher A.E. Late priming and variability of epitope-specific CD8+ T cell responses during a persistent virus infection. J Immunol. 2005, 174:7950-7960.
182. Kern F.G., Pellegrini S., Cowie A., Basilico C. Regulation of polyomavirus late promoter activity by viral early proteins. J Virol. 1986, 60:275-285.
183. Khalili K., Croul S., Del Valle L., Krynska B., Gordon J. Oncogenic potential of human neurotropic virus: laboratory and clinical observations. Isr Med Assoc 2001, J 3:210-215.
184. Kiefer F., Courtneidge S.A., Wagner E.F. Oncogenic properties of the middle T antigens of polyomaviruses. Adv Cancer Res 1994, 64:125-157.
185. Kilham L., Murphy H.W. A pneumotropic virus isolated from C3H mice carrying the Bittner Milk Agent. Proc Soc Exp Biol. Med 1953, 82:133-137.
186. Klein G., Powers A., Croce C. Association of SV40 with human tumors. Oncogene 2002, 21:1141-1149.
187. Klug A. Architectural design of spherical viruses. Nature 1983, 303:378-379.
188. Kornbluth S., Sudol M., Hanafusa H. Association of the poly-omavirus middle-T antigen with c-yes protein. Nature 1987, 325:171-173.
189. Krauzewicz N., Cox C., Soeda E., Clark B., Rayner S., Griffin B.E. Sustained ex vivo and in vivo transfer of a reporter gene using poly-oma virus pseudocapsids. Gene Ther 2000, 7:1094-1102.
190. Krauzewicz N., Stokrova J., Jenkins C., Elliott M., Higgins C.F., Griffin B.E. Virus-like gene transfer into cells mediated by polyoma virus pseudocapsids. Gene Ther 2000, 7:2122-2131.
191. Krauzewicz N., Streuli C.H., Stuart-Smith N., Jones M.D., Wallace S., Griffin B.E. Myristylated polyomavirus VP2: role in the life cycle of the virus. J. Virol. 1990, 64:4414-4420.
192. Krippl B., Griep A.E., Mahon K.A., Bohnlein E., Gruss P., Westphal H. Expression and amplification in transgenic mice of a polyoma virus mutant regulatory region. Nucleic Acids Res 1988, 16:8963-8976.
193. Kupferman M.E., Fini M.E., Muller W.J., Weber R., Cheng Y., Muschel R.J. Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol. 2000, 157:1777-1783.
194. Kypta R.M., Hemming A., Courtneidge S.A. Identification and characterization of p59fyn (a src-like protein tyrosine kinase) in normal and polyoma virus transformed cells. Embo J 1988, 7:3837-3844.
195. Lane D.P., Crawford L.V. T antigen is bound to a host protein in SV40-transformed cells. Nature 1979, 278:261-263.
196. Larose A., Dyson N., Sullivan M., Harlow E., Bastin M. Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization. J. Virol 1991, 65:2308-2313.
197. Law L.W. Immunologic responsiveness and the induction of experi-mental neoplasms. Cancer Res 1966, 26:1121-1134.
198. Law L.W., Dawe C.J. Influence of total body x-irradiation on tumor induction by parotid tumor agent in adult mice. Proc Soc Exp Biol Med 1960, 105:414-419.
199. Law L.W., Ting R.C., Leckband E. Prevention of virus-induced neoplasms in mice through passive transfer of immunity by sensitized syn-geneic lymphoid cells. Proc Natl Acad Sci USA 1967, 57:1068-1075.
200. Law M.F., Takemoto K.K., Howley P.M. Characterization of the genome of the murine papovavirus K. J Virol 1979, 30:90-97.
201. Lencer W.I., Tsai B. The intracellular voyage of cholera toxin: going retro. Trends Biochem Sci 2003, 28:639-645.
202. Lewis B.C., Klimstra D.S., Varmus H.E. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pan-creatic cancer. Genes Dev 2003, 17:3127-3138.
203. Li C.P., Jahnes W.G. Hydrocephalus in suckling mice inoculated with SE polyoma virus. Virology 1959, 9:489-492.
204. Li D., Dower K., Ma Y., Tian Y., Benjamin T.L. A tumor host range selection procedure identifies p150(sal2) as a target of polyoma virus large T antigen. Proc Natl Acad Sci USA 2001, 98:14619-14624.
205. Li D., Tian Y., Ma Y., Benjamin T.L. P150Sal2 Is a p53-independent regulator of p21Cip1/Waf1. Mol. Cell Biolo 2004, 24:3885-3893.
206. Li D., Zhao R., Lilyestrom W., et al. Structure of the replicative heli-case of the oncoprotein SV40 large tumour antigen. Nature 2003, 423:512-518.
207. Li Y., Welm B., Podsypanina K., et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA 2003, 100:15853-15858.
208. Liang T.J., Carmichael G.G., Benjamin T.L. A polyoma mutant that encodes small T antigen but not middle T antigen demonstrates uncou-pling of cell surface and cytoskeletal changes associated with cell transformation. Mol Cell Biol. 1984, 4:2774-2783.
209. Liddington R.C., Yan Y., Moulai J., Sahli R., Benjamin T.L., Harrison S.C. Structure of simian virus 40 at 3.8-A resolution. Nature 1991, 354:278-284.
210. Lilley B.N., Ploegh H.L. A membrane protein required for disloca-tion of misfolded proteins from the ER. Nature 2004, 429:834-840.
211. Lilley B.N., Gilbert J.M., Ploegh H.L., Benjamin T.L. Murine polyomavirus requires the endoplasmic reticulum protein Derlin-2 to initiate infection. J Virol 2006, 80:8739-8744.
212. Lin E.Y, Jones J.G., Li P., et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol. 2003, 163:2113-2126.
213. Lin E.Y, Pollard J.W. Macrophages: modulators of breast cancer progression. Novartis Found Symp 2004, 256:158-168. discussion.
214. Lin E.Y, Pollard J.W. Macrophages: modulators of breast cancer progression. Novartis Found Symp 2004, 256:168-172. discussion.
215. Lin E.Y, Pollard J.W. Macrophages: modulators of breast cancer progression. Novartis Found Symp 2004, 256:259-269. discussion.
216. Linder S., Nilsson M., Martens I., Magnusson G. A viable mouse polyomavirus mutant without immortalizing or transforming activities. Virology 1990, 179:78-86.
217. Linzer D.I., Levine A.J. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 1979, 17:43-52.
218. Ljunggren G., Liunggren H.G., Dalianis T. T cell subsets involved in immunity against polyoma virus-induced tumors. Virology 1994, 198:714-716.
219. Lomax M., Fried M. Polyoma virus disrupts ARF signaling to p53. Oncogene 2001, 20:4951-4960.
220. Lopez P., Vidal F., Rassoulzadegan M., Cuzin F A role of inhibin as a tumor suppressor in Sertoli cells: down-regulation upon aging and repression by a viral oncogene. Oncogene 1999, 18:7303-7309.
221. Lopez-Rios F., Illei P.B., Rusch V., Ladanyi M. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet 2004, 364:1157-1166.
222. Love T.M.d.J.R., Sheng Q., Leger A., Schaffhausen B. Activation of CREB/ATF sites by polyomavirus large T antigen. J Virol 2005, 79:4180-4190.
223. Lukacher A.E., Freund R., Carroll J.P., Bronson R.T., Benjamin T.L. Pyvs: a dominantly acting gene in C3H/BiDa mice conferring susceptibility to tumor induction by polyoma virus. Virology 1993, 196:241-248.
224. Lukacher A.E., Ma Y., Carroll J.P., et al. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J Exp Med 1995, 181:1683-1692.
225. + T cells in vivo during infection and tumor rejection. J Immunol. 1999, 163:3369-3378.
226. Mackay R.L., Consigli R.A. Early events in polyoma virus infec-tion: attachment penetration and nuclear entry. J. Virol. 1976, 19:620-636.
227. Macpherson I., Montagnier L. Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology 1964, 23:291-294.
228. Magnuson B, Rainey E.K., Benjamin T., Baryshev M., Mktrtchian S., Tsai B. Erp29 triggers a conformational change in polyomavirus to stimu-late membrane binding. Molecular Cell 2005, 20:289-300.
229. Mahoney W.M., Hong J.H., Yaffe M.B., Farrance I.K. The transcriptional co-activator TAZ interacts differentially with Transcriptional Enhancer Factor-1 (TEF-1) family members. Biochem J. 2005.
230. Mannova P., Forstova J. Mouse polyomavirus utilizes recycling endosomes for a traffic pathway independent of COPI vesicle transport. J Virol 2003, 77:1672-1681.
231. Markland W., Cheng S.H., Oostra B.A., Smith A.E. In vitro mutagenesis of the putative membrane-binding domain of polyomavirus middle-T antigen. J Virol 1986, 59:82-89.
232. Markland W., Oostra B.A., Harvey R., Markham A.F., Colledge W.H., Smith A.E. Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250. J Virol 1986, 59:384-391.
233. Marti A., Ballmer-Hofer K. Polyomavirus large-and small-T relieve middle-T-induced cell cycle arrest in normal fibroblasts. J. Gen Virol 1999, 80:2917-2921. (Pt11).
234. Mattern CF., Allison A.C., Rowe W.P. Structure and composition of k virus and its relation to the quot;papovavirus quot; group. Virology 1963, 20:413-419.
235. Mattern CF., Takemoto K.K., Daniel W.A. Replication of poly-oma virus in mouse embryo cells: electron microscopic observations. Virology 1966, 30:242-256.
236. May T., Gleiter S., Lilie H. Assessment of cell type specific gene transfer of polyoma virus like particles presenting a tumor specific antibody Fv fragment. J Virol Methods 2002, 105:147-157.
237. Mayer M., Domes K. Nucleotide sequence and genome organi-zation of the murine polyomavirus Kilham strain. Virology 1991, 181:469-480.
238. McCance D.J., Sebesteny A., Griffin B.E., Balkwill F., Tilly R., Gregson N.A. A paralytic disease in nude mice associated with polyoma virus infection. J Gen Virol 1983, 64:57-67. (Pt 1).
239. Mes-Masson A.M., Schaffhausen B., Hassell J.A. The major site of tyrosine phosphorylation in polyomavirus middle T antigen is not required for transformation. J. Virol 1984, 52:457-464.
240. Mezes B.A.A., Paolo Mutations of polyomavirus VP1 allow in vitro growth in undifferentiated cells and modify in vivo tissue replication speci-ficity. J. Virol 1994, 68:1196-1199.
241. Mokhtarian F., Shah K.V. Pathogenesis of K papovavirus infec-tion in athymic nude mice. Infect Immun 1983, 41:434-436.
242. Montross L., Watkins S., Moreland R.B., Mamon H., Caspar D.L., Garcea R.L. Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1. J. Virol. 1991, 65:4991-4998.
243. Mor O., Read M., Fried M. p53in polyoma virus transformed REF52 cells. Oncogene 1997, 15:3113-3119.
244. Moreno C.S., Ramachandran S., Ashby D.G., et al. Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase 2A B56gamma knock-down. Cancer Res 2004, 64:6978-6988.
245. + T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells. J Exp Med 2001, 193:595-606.
246. + T cell responses. Nat Immunol. 2002, 3:189-195.
247. Moser J.M., Lukacher A.E. Immunity to polyoma virus infection and tumorigenesis. Viral Immunol 2001, 14:199-216.
248. Moser A.R., Pitot H.C., Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990, 247:322-324.
249. Moule M.G., Collins C.H., McCormick F., Fried M. Role for PP2A in ARF signaling to p53. Proc Natl Acad Sci USA 2004, 101:14063-14066.
250. Mullane K.P., Ratnofsky M., Cullere X., Schaffhausen B. Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A. Mol Cell Biol 1998, 18:7556-7564.
251. Mylin L.M., Schell T.D., Roberts D., et al. Quantitation of CD8 (+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40 SV40 T-antigen-transformed cells or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes. J Virol 2000, 74:6922-6934.
252. Nagle J.A., Ma Z., Byrne M.A., White M.F., Shaw L.M. Involvement of insulin receptor substrate 2 in mammary tumor metastasis. Mol Cell Biol 2004, 24:9726-9735.
253. Nemethova M., Smutny M., Wintersberger E. Transactivation of E2F-regulated genes by polyomavirus large T antigen: evidence for a two-step mechanism. Mol Cell Biol 2004, 24:10986-10994.
254. Nemethova M., Wintersberger E. Polyomavirus large T antigen binds the transcriptional coactivator protein p300. J Virol 1999, 73:1734-1739.
255. Nilsson S.V., Magnusson G. Activities of polyomavirus large-T-antigen proteins expressed by mutant genes. J Virol 1984, 51:768-775.
256. Nilsson M., Osterlund M., Magnusson G. Analysis of poly-omavirus enhancer-effect on DNA replication and early gene expression. J Mol Biol 1991, 218:479-483.
257. Norkin L.C. Papovaviral persistent infections. Microbiol Rev 1982, 46:384-425.
258. Norkin L.C., Anderson H.A., Wolfrom S.A., Oppenheim A. Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum where the virus disassembles. J Virol 2002, 76:5156-5166.
259. Oliveira M.L., Roberts T.M., Druker B.J., Armelin M.C. Mapping of polyomavirus middle T domain that is responsible for AP-1 activation. Oncogene 1998, 16:2975-2982.
260. Ornitz D.M., Hammer R.E., Messing A., Palmiter R.D., Brinster R.L. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science 1987, 238:188-193.
261. Pallas D.C., Cherington V., Morgan W., et al. Cellular proteins that associate with the middle and small T antigens of polyomavirus. J Virol 1988, 62:3934-3940.
262. Pallas D.C., Shahrik L.K., Martin B.L., et al. Polyoma small and middle T antigens and SV40 small T antigen form stable complexes with protein phosphatase 2A. Cell 1990, 60:167-176.
263. Palmiter R.D., Chen H.Y., Messing A., Brinster R.L. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice. Nature 1985, 316:457-460.
264. Paquis-Flucklinger V., Michiels J.F., Vidal F., et al. Expression in transgenic mice of the large T antigen of polyomavirus induces Sertoli cell tumours and allows the establishment of differentiated cell lines. Oncogene 1993, 8:2087-2094.
265. Park K.S., Whitsett J.A., Di Palma T., Hong J.H., Yaffe M.B., Zannini M. TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. J Biol. Chem 2004, 279:17384-17390.
266. Parsons D.F. Morphology of K virus and its relation to the papova group of viruses. Virology 1963, 20:385-387.
267. Pelkmans L., Kartenbeck J., Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 2001, 3:473-483.
268. Pelkmans L., Puntener D., Helenius A. Local actin polymeriza-tion and dynamin recruitment in SV40-induced internalization of caveolae. Science 2002, 296:535-539.
269. Peschon J.J., Behringer R.R., Cate R.L., et al. Directed expression of an oncogene to Sertoli cells in transgenic mice using mullerian inhibiting substance regulatory sequences. Mol Endocrinol 1992, 6:1403-1411.
270. Pipas J.M. Common and unique features of T antigens encoded by the polyomavirus group. J Virol 1992, 66:3979-3985.
271. Ploegh H.L. Viral strategies of immune evasion. Science 1998, 280:248-253.
272. Politi K., Kljuic A., Szabolcs M., Fisher P., Ludwig T., Efstratiadis A. quot;Designer quot; tumors in mice. Oncogene 2004, 23:1558-1565.
273. Politi K., Szabolcs M., Fisher P., Kljuic A., Ludwig T., Efstratiadis A. A mouse model of uterine leiomyosarcoma. Am J Pathol 2004, 164:325-336.
274. Pollack R., Osborn M., Weber K. Patterns of organization of actin and myosin in normal and transformed cultured cells. Proc Natl Acad Sci USA 1975, 72:994-998.
275. Poulin D.L., DeCaprio J.A. Is there a role for SV 40 in human cancer?. J Clin Oncol 2006, 24:4356-4365.
276. Putzer B.M., Bramson J.L., Addison CL., et al. Combination therapy with interleukin-2 and wild-type p53expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer. Hum Gene Ther 1998, 9:707-718.
277. Qian W., Kashuba E., Magnusson K.P., et al. Role of p53mutation in polyomavirus-induced tumorigenesis. J. Gen Virol. 1997, 78:893-903. (Pt 4).
278. Raptis L., Lamfrom H., Benjamin T.L. Regulation of cellular phenotype and expression of polyomavirus middle T antigen in rat fibrob-lasts. Mol Cell Biol 1985, 5:2476-2486.
279. Rassoulzadegan M., Courtneidge S.A., Loubiere R., el Baze P., Cuzin F. A variety of tumours induced by the middle T antigen of polyoma virus in a transgenic mouse family. Oncogene 1990, 5:1507-1510.
280. Rassoulzadegan M., Cowie A., Carr A., Glaichenhaus N., Kamen R., Cuzin F. The roles of individual polyoma virus early proteins in oncogenic transformation. Nature 1982, 300:713-718.
281. Rayment I., Baker T.S., Caspar D.L., Murakami W.T. Polyoma virus capsid structure at 22.5 A resolution. Nature 1982, 295:110-115.
282. Reed W.B., Lopez D.A., Landing B. Clinical spectrum of anhidrotic ectodermal dysplasia. Arch Dermatol 1970, 102:134-143.
283. Ricci L., Maione R., Passananti C., Felsani A., Amati P. Mutations in the VP1 coding region of polyomavirus determine differentiat-ing stage specificity. J Virol 1992, 66:7153-7158.
284. Richterova Z., Liebl D., Horak M., et al. Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei. J Virol 2001, 75:10880-10891.
285. Rochford R., Campbell B.A., Villarreal L.P. Genetic analysis of the enhancer requirements for polyomavirus DNA replication in mice. J Virol 1990, 64:476-485.
286. Rochford R., Moreno J.P., Peake M.L., Villarreal L.P. Enhancer dependence of polyomavirus persistence in mouse kidneys. J Virol 1992, 66:3287-3297.
287. Rondinelli R.H., Haslam S.Z., Fluck M.M. The role of ovarian hormones age and mammary gland development in polyomavirus mammary tumorigenesis. Oncogene 1995, 11:1817-1827.
288. Rowe W.P. The epidemiology of mouse polyoma virus infection. Bacteriol Rev 1961, 25:18-31.
289. Rowe W.P., Hartley J.W., Estes J.D., Huebner R.J. Studies of mouse polyoma virus infection. I. Procedures for quantitation and detection of virus. J Exp Med 1959, 109:379-391.
290. Rowe W.P., Hartley J.W., Law L.W., Huebner R.J. Studies of mouse polyoma virus infection. III. Distribution of antibodies in laboratory mouse colonies. J. Exp Med 1959, 109:449-462.
291. Rowe W.P., Huebner R.J., Hartley J.W Ecology of a mouse tumor virus. Perspectives in virology 1961, 2:177-190.
292. Saenz Robles M.T., Symonds H., Chen J., Van Dyke T. Induction versus progression of brain tumor development: differential functions for the pRB-and p53-targeting domains of simian virus 40 T antigen. Mol Cell Biol 1994, 14:2686-2698.
293. Sahli R., Freund R., Dubensky T., Garcea R., Bronson R., Benjamin T. Defect in entry and altered pathogenicity of a polyoma virus mutant blocked in VP2 myristylation. Virology 1993, 192:142-153.
294. Salunke D.M., Caspar D.L., Garcea R.L. Self-assembly of purified polyomavirus capsid protein VP1. Cell 1986, 46:895-904.
295. 1. Biophysical 1989, 56:887-900.
296. Sandgren E.P., Quaife C.J., Pinkert C.A., Palmiter R.D., Brinster R.L. Oncogene-induced liver neoplasia in transgenic mice. Oncogene 1989, 4:715-724.
297. Sanjuan N., Zijlstra M., Carroll J., Jaenisch R., Benjamin T. Infection by polyomavirus of murine cells deficient in class I major histo-compatibility complex expression. J Virol 1992, 66:4587-4590.
298. Schaffhausen B.S., Benjamin T.L. Deficiency in histone acetyla-tion in nontransforming host range mutants of polyoma virus. Proc Natl Acad Sci USA 1976, 73:1092-1096.
299. Schaffhausen B.S., Silver J.E., Benjamin T.L. Tumor antigen (s) in cell productively infected by wild-type polyoma virus and mutant NG-18. Proc Natl Acad Sci USA 1978, 75:79-83.
300. Schell T.D., Knowles B.B., Tevethia S.S. Sequential loss of cyto-toxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas. Cancer Res 2000, 60:3002-3012.
301. Schell T.D., Lippolis J.D., Tevethia S.S. Cytotoxic T lymphocytes from HLA-A2.1 transgenic mice define a potential human epitope from simian virus 40 large T antigen. Cancer Res 2001, 61:873-879.
302. Schell T.D., Mylin L.M., Georgoff I., Teresky A.K., Levine A.J., Tevethia S.S. Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice. J Virol 1999, 73:5981-5993.
303. Schuchner S., Nemethova M., Belisova A., Klucky B., Holnthoner W., Wintersberger E. Transactivation of murine cyclin A by polyomavirus large and small T antigens. J Virol 2001, 75:6498-6507.
304. Schuchner S., Wintersberger E. Binding of polyomavirus small T antigen to protein phosphatase 2A is required for elimination of p27and support of S-phase induction in concert with large T antigen. J. Virol. 1999, 73:9266-9273.
305. Sebesteny A., Tilly R., Balkwill E, Trevan D. Demyelination and wasting associated with polyomavirus infection in nude (nu/nu) mice. Lab Anim 1980, 14:337-345.
306. Seki M., Enomoto T., Eki T., et al. DNA helicase and nucleoside-5'-triphosphatase activities of polyoma virus large tumor antigen. Biochemistry 1990, 29:1003-1009.
307. Sekikawa K., Levine A.J. Isolation and characterization of poly-oma host range mutants that replicate in nullipotential embryonal carcinoma cells. Proc Natl Acad Sci USA 1981, 78:1100-1104.
308. Shah K.V., Galloway D.A., Knowles W.A., Viscidi R.P. Simian virus 40 (SV40) and human cancer: a review of the serological data. Rev Med Virol 2004, 14:231-239.
309. Shay J.W., Wright W.E. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis. 2004.
310. Sheng Q., Denis D., Ratnofsky M., Roberts T.M., DeCaprio J.A., Schaffhausen B. The DnaJ domain of polyomavirus large T antigen is required to regulate Rb family tumor suppressor function. J Virol 1997, 71:9410-9416.
311. Shin Y.C., Folk W.R. Formation of polyomavirus-like particles with different VP1 molecules that bind the urokinase plasminogen activator receptor. J. Virol. 2003, 77:11491-11498.
312. Shollar D., Del Valle L., Khalili K., Otte J., Gordon J. JCV T-antigen interacts with the neurofibromatosis type 2 gene product in a trans-genic mouse model of malignant peripheral nerve sheath tumors. Oncogene 2004, 23:5459-5467.
313. Silver J., Schaffhausen B., Benjamin T. Tumor antigens induced by nontransforming mutants of polyoma virus. Cell 1978, 15:485-496.
314. Simmons D.T. SV40 large T antigen functions in DNA replication and transformation. Adv Virus Res 2000, 55:75-134.
315. Skoczylas C., Fahrbach K.M., Rundell K. Cellular targets of the SV40 small-t antigen in human cell transformation. Cell Cycle 2004, 3:606-610.
316. Slilaty S.N., Aposhian H.V. Gene transfer by polyoma-like parti-cles assembled in a cell-free system. Science 1983, 220:725-727.
317. Smolar N., Griffin B.E. DNA sequences of polyoma virus early deletion mutants. J. Virol. 1981, 38:958-967.
318. Soeda E., Arrand J.R., Smolar N., Walsh J.E., Griffin B.E. Coding potential and regulatory signals of the polyoma virus genome. Nature 1980, 283:445-453.
319. Soeda E., Griffin B.E. Sequences from the genome of a non-transforming mutant of polyoma virus. Nature 1978, 276:294-298.
320. Sottocornola E., Colombo I., Vergani V., Taraboletti G., Berra B. Increased tumorigenicity and invasiveness of C6 rat glioma cells transfected with the human alpha-28 sialyltransferase cDNA. Invasion Metastasis 1998, 18:142-154.
321. Stamatos N.M., Chakrabarti S., Moss B., Hare J.D. Expression of polyomavirus virion proteins by a vaccinia virus vector: association of VP1 and VP2 with the nuclear framework. J Virol 1987, 61:516-525.
322. + T cell effector function in SV40 T antigen transgenic mice. J Immunol 2003, 171:697-707.
323. Stehle T., Gamblin S.J., Yan Y., Harrison S.C. The structure of simian virus 40 refined at 3.1 A resolution. Structure 1996, 4:165-182.
324. Stehle T., Harrison S.C. Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. Structure 1996, 4:183-194.
325. Stehle T., Harrison S.C. High-resolution structure of a polyomavirus VP1-oligosac-charide complex: implications for assembly and receptor binding. Embo J 1997, 16:5139-5148.
326. Stehle T., Yan Y., Benjamin T.L., Harrison S.C. Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 1994, 369:160-163.
327. Stewart S.A., Weinberg R.A. Telomerase and human tumorigene-sis. Semin Cancer Biol. 2000, 10:399-406.
328. Stewart S.E. The polyomavirus section a. Adv Virus Res. 1960, 1:61-90.
329. Stewart S.E., Eddy B.E., Borgese N. Neoplasms in mice inocu-lated with a tumor agent carried in tissue culture. J. Natl Cancer Inst 1958, 20:1223-1243.
330. Stewart S.E., Eddy B.E., Irwin M., Lee S. Development of resist-ance in mice to tumour induction by S E polyoma virus. Nature 1960, 186:615-617.
331. Stoker M. Abortive transformation by polyoma virus. Nature 1968, 218:234-238.
332. Streuli C.H., Griffin B.E. Myristic acid is coupled to a structural protein of polyoma virus and SV40. Nature 1987, 326:619-622.
333. Stubenrauch K., Gleiter S., Brinkmann U., Rudolph R., Lilie H. Conjugation of an antibody Fv fragment to a virus coat protein: cell-specific targeting of recombinant polyoma-virus-like particles. Biochem J 2001, 356:867-873.
334. Su L.K., Kinzler K.W., Vogelstein B., et al. Multiple intestinal neo-plasia caused by a mutation in the murine homolog of the APC gene. Science 1992, 256:668-670.
335. Su W., Liu W., Schaffhausen B.S., Roberts T.M. Association of polyomavirus middle tumor antigen with phospholipase C-gamma 1. J Biol Chem 1995, 270:12331-12334.
336. Symonds H., Krall L., Remington L., et al. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 1994, 78:703-711.
337. Szomolanyi-Tsuda E., Brien J.D., Dorgan J.E., Garcea R.L., Woodland R.T., Welsh R.M. Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells. Virology 2001, 280:160-168.
338. Szomolanyi-Tsuda E., Brien J.D., Dorgan J.E., Welsh R.M., Garcea R.L. The role of CD40-CD154 interaction in antiviral T cell-independent IgG responses. J Immunol 2000, 164:5877-5882.
339. Szomolanyi-Tsuda E., Dundon P.L., Joris L, Shultz L.D., Woda B.A., Welsh R.M. Acute lethal natural killer cell-resistant myeloprolifer-ative disease induced by polyomavirus in severe combined immunodeficient mice. Am J Pathol 1994, 144:359-371.
340. Szomolanyi-Tsuda E., Le Q.P., Garcea R.L., Welsh R.M. T-cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles. J Virol 1998, 72:6665-6670.
341. Szomolanyi-Tsuda E., Welsh R.M. T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J Exp Med 1996, 183:403-411.
342. Takemoto K.K., Fabisch P. Transformation of mouse cells by K-papovavirus. Virology 1970, 40:135-143.
343. Talmage D.A., Freund R., Dubensky T., et al. Heterogeneity in state and expression of viral DNA in polyoma virus-induced tumors of the mouse. Virology 1992, 187:734-747.
344. Talmage D.A., Freund R., Young A.T., Dahl J., Dawe C.J., Benjamin T.L. Phosphorylation of middle T by pp60c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis. Cell 1989, 59:55-65.
345. Tannhauser S.J. Hereditary ectodermal dysplasia of the quot;anhidrotic quot; type: with symptoms of adrenal medulla insufficiency and with abnormali-ties of the bones of the skull. J Am. Med. Assoc. 1936, 106:908-910.
346. Tegerstedt K., Andreasson K., Vlastos A., Hedlund K.O., Dalianis T., Ramqvist T. Murine pneumotropic virus VP1 virus-like particles (VLPs) bind to several cell types independent of sialic acid residues and do not serologically cross react with murine polyomavirus VP1 VLPs. J Gen Virol 2003, 84:3443-3452.
347. Templeton D., Eckhart W. Mutation causing premature termina-tion of the polyoma virus medium T antigen blocks cell transformation. J Virol 1982, 41:1014-1024.
348. Templeton D., Simon S., Eckhart W. Truncated forms of the poly-omavirus middle T antigen can substitute for the small T antigen in lytic infection. J Virol 1986, 57:367-370.
349. Tevethia M.J., Bonneau R.H., Griffith J.W., Mylin L. A simian virus 40 large T-antigen segment containing amino acids 1 to 127 and expressed under the control of the rat elastase-1 promoter produces pancre-atic acinar carcinomas in transgenic mice. J Virol 1997, 71:8157-8166.
350. Tevethia S., Beachy T., Schell T., et al. Role of CTL host responses and their implication for tumorigenicity testing and the use of tumour cells as vaccine substrate. Dev Biol. (Basel) 2001, 106:109-121. discussion.
351. Tevethia S., Beachy T., Schell T., et al. Role of CTL host responses and their implication for tumorigenicity testing and the use of tumour cells as vaccine substrate. Dev Biol. (Basel) 2001, 106:143-160. discussion.
352. Tevethia S.S., Epler M., Georgoff I., Teresky A., Marlow M., Levine A.J. Antibody response to human papovavirus JC (JCV) and simian virus 40 (SV40) T antigens in SV40 T antigen-transgenic mice. Virology 1992, 190:459-464.
353. Thomas J.E., Aguzzi A., Soriano P., Wagner E.F., Brugge J.S. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src. Oncogene 1993, 8:2521-2529.
354. Tian Y., Li D., Dahl J., You J., Benjamin T.L. Identification of TAZ as a binding partner of the polyoma virus T antigens. J. Virol 2004, 78:12259-12267.
355. Ting R.C., Law L.W. The role of thymus in transplantation resist-ance induced by polyoma virus. J Natl Cancer Inst 1965, 34:521-527.
356. Tonietti G., Oldstone M.B., Dixon F.J. The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice. J Exp Med 1970, 132:89-109.
357. Treisman R., Cowie A., Favaloro J., Jat P., Kamen R. The struc-tures of the spliced mRNAs encoding polyoma virus early region proteins. J Mol Appl Genet 1981, 1:83-92.
358. Treisman R., Novak U., Favaloro J., Kamen R. Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein. Nature 1981, 292:595-600.
359. Trotot P., Mechali F., Blangy D., Lacasa M. Transcriptional activity in 3T3 F9 and PCC4 embryonal carcinoma cells: a systematic deletion and linker-scanning study of the polyomavirus enhancer. Virology 1994, 202:724-734.
360. Tsai B., Gilbert J.M., Stehle T., Lencer W., Benjamin T.L., Rapoport T.A. Gangliosides are receptors for murine polyoma virus and SV40. Embo J 2003, 22:4346-4355.
361. Tyndall C., La Mantia G., Thacker C.M., Favaloro J., Kamen R. A region of the polyoma virus genome between the replication origin and late protein coding sequences is required in cis for both early gene expres-sion and viral DNA replication. Nucleic Acids Res 1981, 9:6231-6250.
362. Ugi S., Imamura T., Ricketts W., Olefsky J.M. Protein phos-phatase 2A forms a molecular complex with Shc and regulates Shc tyrosine phosphorylation and downstream mitogenic signaling. Mol Cell Biol 2002, 22:2375-2587.
363. Velupillai P., Carroll J.P., Benjamin T.L. Susceptibility to poly-omavirus-induced tumors in inbred mice: role of innate immune responses. J Virol 2002, 76:9657-9663.
364. Velupillai P., Garcea R., Benjamin T. Polyoma virus-like particles elicit polarized cytokine responses in ASPCs from tumor-susceptible and-resistant mice. J. Immunol 2006, 176:1148-1153.
365. Velupillai P., Yoshizawa I., Dey D.C., et al. Wild-derived inbred mice have a novel basis of susceptibility to polyomavirus-induced tumors. J Virol 1999, 73:10079-10085.
366. Vilchez R.A., Butel J.S. Emergent human pathogen simian virus 40 and its role in cancer. Clin Microbiol Rev 2004, 17:495-508. table of contents.
367. Walter G., Ruediger R., Slaughter C., Mumby M. Association of protein phosphatase 2A with polyoma virus medium tumor antigen. Proc Natl Acad Sci USA 1990, 87:2521-2525.
368. Wang R., Bautch V.L. The polyomavirus early region gene in transgenic mice causes vascular and bone tumors. J Virol 1991, 65:5174-5183.
369. Watanabe G., Howe A., Lee R.J., et al. Induction of cyclin Dl by simian virus 40 small tumor antigen. Proc Natl Acad Sci USA 1996, 93:2861-2866.
370. Whalen K., de Jesus R., Kean J., Schaffhausen B. Genetic analysis of the polyomavirus DnaJ domain. J.Virol. 2005, 79:9982-9990.
371. White M.K., Khalili K. Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology 2004, 324:1-16.
372. Williams R.L., Courtneidge S.A., Wagner E.F. Embryonic lethal-ities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell 1988, 52:121-131.
373. Williams R.L., Risau W., Zerwes H.G., Drexler H., Aguzzi A., Wagner E.F. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell 1989, 57:1053-1063.
374. Wong M., Pagano J.S., Schiller J.T., Tevethia S.S., Raab-Traub N., Gruber J. New associations of human papillomavirus Simian virus 40 and Epstein-Barr virus with human cancer. J. Natl Cancer Inst 2002, 94:1832-1836.
375. Xie A.Y., Bermudez V.P., Folk W.R. Stimulation of DNA replication from the polyomavirus origin by PCAF and GCN5 acetyltransferases: acetylation of large T antigen. Mol Cell Biol 2002, 22:7907-7918.
376. Yelton D.B., Aposhian H.V. Polyoma pseudovirions. I. Sequence of events in primary mouse embryo cells leading to pseudovirus production. J Virol 1972, 10:340-346.
377. Zhang S., Magnusson G. Kilham polyomavirus: activation of gene expression and DNA replication in mouse fibroblast cells by an enhancer substitution. J Virol 2001, 75:10015-10023.
378. Zhang S., Magnusson G. Cellular mobile genetic elements in the regulatory region of the pneumotropic mouse polyomavirus genome: structure and function in viral gene expression and DNA replication. J Virol 2003, 77:3477-3486.
379. Zheng X., Gao J.X., Zhang H., Geiger T.L., Liu Y., Zheng P. Clonal deletion of simian virus 40 large T antigen-specific T cells in the transgenic adenocarcinoma of mouse prostate mice: an important role for clonal deletion in shaping the repertoire of T cells specific for antigens over-expressed in solid tumors. J Immunol 2002, 169:4761-4769.
380. Zhu L., Hathcock K.S., Hande P., Lansdorp P.M., Seldin M.F., Hodes R.J. Telomere length regulation in mice is linked to a novel chromo-some locus. Proc Natl Acad Sci USA 1998, 95:8648-8653.
381. Zijlmans J.M., Martens U.M., Poon S.S., et al. Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc Natl Acad Sci USA 1997, 94:7423-7428.
382. Zimmer G., Klenk H.D., Herrler G. Identification of a 40-kDa cell surface sialoglycoprotein with the characteristics of a major influenza C virus receptor in a Madin-Darby canine kidney cell line. J Biol Chem 1995, 270:17815-17822.
383. 1 and the viral early proteins. Proc Natl Acad Sci USA 1987, 84:1210-1214.
384. zur Hausen H. Viruses in human cancers. Science 1991, 254:1167-1173.